INS and diabetes mellitus: Hyperglycemia and other metabolic abnormalities associated with diabetes activate the NF-κB pathway, leading to the overproduction of pro-inflammatory cytokines like TNF-α and IL-6, which interfere with insulin signaling giving rise to mutual amplification of inflammation [132].